Table of Content

Table of Contents

Global Over-the-Counter Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Over-the-Counter Drugs Market by Value
2.2.1 Global Over-the-Counter Drugs Revenue by Type
2.2.2 Global Over-the-Counter Drugs Market by Value (%)
2.3 Global Over-the-Counter Drugs Market by Production
2.3.1 Global Over-the-Counter Drugs Production by Type
2.3.2 Global Over-the-Counter Drugs Market by Production (%)

3. The Major Driver of Over-the-Counter Drugs Industry
3.1 Historical & Forecast Global Over-the-Counter Drugs Demand
3.2 Largest Application for Over-the-Counter Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Over-the-Counter Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Over-the-Counter Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Over-the-Counter Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Over-the-Counter Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Over-the-Counter Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Over-the-Counter Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Over-the-Counter Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Over-the-Counter Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Over-the-Counter Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Over-the-Counter Drugs Average Price Trend
12.1 Market Price for Each Type of Over-the-Counter Drugs in US (2018-2022)
12.2 Market Price for Each Type of Over-the-Counter Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Over-the-Counter Drugs in China (2018-2022)
12.4 Market Price for Each Type of Over-the-Counter Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Over-the-Counter Drugs in India (2018-2022)
12.6 Market Price for Each Type of Over-the-Counter Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Over-the-Counter Drugs in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Over-the-Counter Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Over-the-Counter Drugs

14. Over-the-Counter Drugs Competitive Landscape
14.1 Johnson & Johnson
14.1.1 Johnson & Johnson Company Profiles
14.1.2 Johnson & Johnson Product Introduction
14.1.3 Johnson & Johnson Over-the-Counter Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Merck
14.2.1 Merck Company Profiles
14.2.2 Merck Product Introduction
14.2.3 Merck Over-the-Counter Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Novartis
14.3.1 Novartis Company Profiles
14.3.2 Novartis Product Introduction
14.3.3 Novartis Over-the-Counter Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Pfizer
14.4.1 Pfizer Company Profiles
14.4.2 Pfizer Product Introduction
14.4.3 Pfizer Over-the-Counter Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Sanofi
14.5.1 Sanofi Company Profiles
14.5.2 Sanofi Product Introduction
14.5.3 Sanofi Over-the-Counter Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Teva Pharmaceutical Industries
14.6.1 Teva Pharmaceutical Industries Company Profiles
14.6.2 Teva Pharmaceutical Industries Product Introduction
14.6.3 Teva Pharmaceutical Industries Over-the-Counter Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Sun Pharmaceutical Industries
14.7.1 Sun Pharmaceutical Industries Company Profiles
14.7.2 Sun Pharmaceutical Industries Product Introduction
14.7.3 Sun Pharmaceutical Industries Over-the-Counter Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 GlaxoSmithKline
14.8.1 GlaxoSmithKline Company Profiles
14.8.2 GlaxoSmithKline Product Introduction
14.8.3 GlaxoSmithKline Over-the-Counter Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Boehringer Ingelheim
14.9.1 Boehringer Ingelheim Company Profiles
14.9.2 Boehringer Ingelheim Product Introduction
14.9.3 Boehringer Ingelheim Over-the-Counter Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Bayer
14.10.1 Bayer Company Profiles
14.10.2 Bayer Product Introduction
14.10.3 Bayer Over-the-Counter Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Alkem Laboratories
14.12 Glenmark Pharmaceuticals
14.13 Cipla
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Over-the-Counter Drugs Industry (Volume)
Figure 2. Over-the-Counter Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Over-the-Counter Drugs Revenue in 2022
Figure 5. US Over-the-Counter Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Over-the-Counter Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Over-the-Counter Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Over-the-Counter Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Over-the-Counter Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Over-the-Counter Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Over-the-Counter Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Over-the-Counter Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Over-the-Counter Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Over-the-Counter Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Over-the-Counter Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Over-the-Counter Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Over-the-Counter Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Over-the-Counter Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Over-the-Counter Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Over-the-Counter Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Over-the-Counter Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Over-the-Counter Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Over-the-Counter Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Over-the-Counter Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Over-the-Counter Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Over-the-Counter Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Over-the-Counter Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Over-the-Counter Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Over-the-Counter Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Over-the-Counter Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Johnson & Johnson Profiles
Table 61. Johnson & Johnson Over-the-Counter Drugs Product Introduction
Table 62. Johnson & Johnson Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Johnson & Johnson Strategic initiatives
Table 64. Merck Profiles
Table 65. Merck Over-the-Counter Drugs Product Introduction
Table 66. Merck Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck Strategic initiatives
Table 68. Novartis Profiles
Table 69. Novartis Over-the-Counter Drugs Product Introduction
Table 70. Novartis Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Novartis Strategic initiatives
Table 72. Pfizer Profiles
Table 73. Pfizer Over-the-Counter Drugs Product Introduction
Table 74. Pfizer Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Pfizer Strategic initiatives
Table 76. Sanofi Profiles
Table 77. Sanofi Over-the-Counter Drugs Product Introduction
Table 78. Sanofi Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Sanofi Strategic initiatives
Table 80. Teva Pharmaceutical Industries Profiles
Table 81. Teva Pharmaceutical Industries Over-the-Counter Drugs Product Introduction
Table 82. Teva Pharmaceutical Industries Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Teva Pharmaceutical Industries Strategic initiatives
Table 84. Sun Pharmaceutical Industries Profiles
Table 85. Sun Pharmaceutical Industries Over-the-Counter Drugs Product Introduction
Table 86. Sun Pharmaceutical Industries Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Sun Pharmaceutical Industries Strategic initiatives
Table 88. GlaxoSmithKline Profiles
Table 89. GlaxoSmithKline Over-the-Counter Drugs Product Introduction
Table 90. GlaxoSmithKline Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. GlaxoSmithKline Strategic initiatives
Table 92. Boehringer Ingelheim Profiles
Table 93. Boehringer Ingelheim Over-the-Counter Drugs Product Introduction
Table 94. Boehringer Ingelheim Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Boehringer Ingelheim Strategic initiatives
Table 97. Bayer Profiles
Table 98. Bayer Over-the-Counter Drugs Product Introduction
Table 99. Bayer Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Bayer Strategic initiatives
Table 101. Alkem Laboratories Profiles
Table 102. Alkem Laboratories Over-the-Counter Drugs Product Introduction
Table 103. Alkem Laboratories Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Alkem Laboratories Strategic initiatives
Table 105. Glenmark Pharmaceuticals Profiles
Table 106. Glenmark Pharmaceuticals Over-the-Counter Drugs Product Introduction
Table 107. Glenmark Pharmaceuticals Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Glenmark Pharmaceuticals Strategic initiatives
Table 109. Cipla Profiles
Table 110. Cipla Over-the-Counter Drugs Product Introduction
Table 111. Cipla Over-the-Counter Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Cipla Strategic initiatives